
Keywords: Cancer metabolism; Combinatory therapy; Glutaminase isoenzymes; Glutamine; Glutaminase inhibitors; Metabolic reprogramming; DON; 6-diazo-5-oxy-L-norleucine; EATC; Ehrlich ascites tumour cells; ERK; extracellular signal-regulated kinases; GA; glutaminase;